Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-014224
Filing Date
2021-11-08
Accepted
2021-11-08 17:07:06
Documents
10

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2193478
2 GRAPHIC g241143g01q92.jpg GRAPHIC 156302
3 GRAPHIC g241143g01w95.jpg GRAPHIC 120391
4 GRAPHIC g241143g06d72.jpg GRAPHIC 123393
5 GRAPHIC g241143g19x87.jpg GRAPHIC 62453
6 GRAPHIC g241143g22f22.jpg GRAPHIC 105626
7 GRAPHIC g241143g40e22.jpg GRAPHIC 160057
8 GRAPHIC g241143g86c02.jpg GRAPHIC 37470
9 GRAPHIC g241143g86d55.jpg GRAPHIC 166435
10 GRAPHIC g241143g92y88.jpg GRAPHIC 173723
  Complete submission text file 0000950123-21-014224.txt   3713114
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

EIN.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-05663 | Film No.: 211388837
SIC: 2836 Biological Products, (No Diagnostic Substances)